Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSB2101100	NKTR-214	bempegaldesleukin	Injection	Biological Products	Supplementary Application	2021-12-06		Patheon Manufacturing Services LLC;Nektar Therapeutics			view
JXSL2101137	NKTR-214	bempegaldesleukin	Injection	Biological Products(1)	Import Drug Application	2021-11-24		BRISTOL-MYERS Squibb (CHINA) Co Ltd;Nektar Therapeutics			view
JXSL2101136	NKTR-214	bempegaldesleukin	Injection	Biological Products(1)	Import Drug Application	2021-11-24		BRISTOL-MYERS Squibb (CHINA) Co Ltd;Nektar Therapeutics			view
JXSB2101072	NKTR-214	bempegaldesleukin	Injection	Biological Products	Supplementary Application	2021-10-21		Patheon Manufacturing Services LLC;Nektar Therapeutics			view
JXSB2101071	NKTR-214	bempegaldesleukin	Injection	Biological Products	Supplementary Application	2021-10-21		Patheon Manufacturing Services LLC;Nektar Therapeutics			view
JXSL2000009	NKTR-214	bempegaldesleukin	Injection	Biological Products	Import Drug Application	2020-01-21	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Nektar Therapeutics	In Review	2020-01-20	view